Formulation Optimization of Citalopram Hydrobromide Thermosensitive Nasal Gel and Its In Vitro Properties
CONG Zhi-xin1,2, LI Shuang1,2, HUANG Jing1,2, WU Chun-zhi2, GU Fu-gen2*
1. School of Pharmacy, Inner Mongolia Medical University, Hohhot 010110, China; 2. Affiliated Hospital, Inner Mongolia Medical University, Hohhot 010050, China
Abstract：OBJECTIVE To optimize the formulation of citalopram hydrobromide (CTH ) thermosensitive nasal gel and further evaluate its in vitro properties. METHODS With gelling temperature and gelling time as evaluating indexes, central composite design-response surface and single factor experimental design method were used to optimize the formulation of CTH thermosensitive nasal gel by using poloxamer 407(F127) and carbomer 940 (CP940) as gel materials. Meanwhile, nasal mucosa permeation enhancer for CTH was then sieved by using Franz diffusion cell and ex vivo sheep nasal mucosa as experimental model. Finally, CTH thermosensitive nasal gel was prepared with cold method and then its in vitro properties was evaluated. In vitro cumulative erosion and cumulative release rate of the drug thermosensitive nasal gel were investigated by membrane-free dissolution method and dialysis membrane method, respectively. Moreover, the effect of temperature and pH on the viscosity of the drug nasal gel formulation was also evaluated. RESULTS The optimal formulation of the thermosensitive nasal gel consisted of CTH 8.0%, F127 20.27%, CP940 0.17%, DM-β-CD 3.0%, ethylparaben 0.05% and distilled water. The gelling temperature, gelling time and pH of the drug thermosensitive nasal gel were found to be about 32.5 ℃,42 s and 5.0, respectively. The in vitro cumulative erosion and cumulative release percentage were both greater than 90% in 55 min and furthermore there was good linear correlation between these two parameters (r=0.998 6). Additionally, in vitro cumulative release of the drug from the gel formulation was determined to be 92% within 8 h, which conformed to Higuchi kinetic equation. Furthermore, the viscosity of the drug nasal gel was influenced by temperature as well as pH in different extent. CONCLUSION The optimized formulation of the CTH thermosensitive nasal gel with central composite design-response surface method and single factor design method shows suitable gelling temperature, gelling time, pH value for nasal preparation and obvious in vitro drug sustained release characteristics.
XU M Y,WANG Y,ZHAO Y, et al. Effect of Ganmai Dazao Decoction on BDNF and SERT gene expression in prefrontal lobe and amygdala and on serum level of 5-HT in rats with depression [J]. Shanghai J Tradit Chin Med(上海中医药杂志),2019,53(3):89-92.
[2]
LI Y,HE M,ZHANG L Y,et al. Advances in the neuroanatomy and pathophysiology of depression [J]. Anhui Med Pharm J(安徽医药),2017,21(10):1751-1759.
[3]
BEZCHLIBNYK-BUTLER K, ALEKSIC I, KENNEDY S H. Citalopram-a review of pharmacological and clinical effects[J]. J Psychiatry Neurosci,2000,25(3):241-254.
[4]
ZHAO L, CAO M H. Clinical effect of citalopram hydrobromide in the treatment of medium term Parkinson′s disease patients with depression[J]. Chin Comm Doc(中国社区医师), 2016, 32(34):98.
[5]
HUANG C T, TSAI M J, LIN Y H, et al. Effect of microemulsions on transdermal delivery of citalopram:optimization studies using mixture design and response surface methodology[J]. Int J Nanomed, 2013, 8(1):2295-2304.
[6]
PARDESHI C V, BELGAMWAR V S. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier:an excellent platform for brain targeting[J]. Expert Opin Drug Del, 2013, 10(7):957-972.
[7]
MARZOUK M A,OSMAN D A,ABD EL-FATTAH A I. Formulation and in vitro evaluation of a thermoreversible mucoadhesive nasal gel of itopride hydrochloride[J]. Drug Dev Ind Pharm,2018,44(11):1857-1867.
[8]
HE Y Z.Characteristics of carbomer and its applications in pharmaceutics[J].Chin J Clin Rational Drug Use(临床合理用药杂志),2019,12(15):180-181.
[9]
BALAKRISHNAN P, PARK E K, SONG C K, et al. Carbopol-incorporated thermoreversible gel for intranasal drug delivery[J]. Molecules, 2015, 20(3):4124-4135.
[10]
HUANG Q Y, XIONG L, WANG H M, et al. Optimization for preparation technology of Cangai volatile oil dextrin inclusion compound/ in situ nasal thermosensitive gel by central composite design-response surface method[J]. Chin J Inf Tradit Chin Med (中国中医药信息杂志),2016,23(11):86-89.
[11]
LI X L,YE Y L,PENG J, et al. Study on preparation of compound metronidazole gel[J]. J Chin Prescr Drug (中国处方药),2018,16(6):29-30.
[12]
XIANG B P. Study on a HPLC method for analysis of citalopram hydrobromide [J]. Sichuan Chem Ind (四川化工), 2007,10 (6):30-31,37.
[13]
HAO W Q, LIN Y, YUAN X, et al. Preparation of salviae miltiorrhiza and ligustrazine hydrochloride nasal thermosensitive in situ gel and study on characterization of its nasal mucosal permeability [J]. J Chin Med Mat(中药材),2016,39(7):1605-1609.
[14]
ZHANG C Y,ZHAO Y C,FAN Y F. Preparation and in vitro release of norfloxacin thermosensitive in situ gel for vaginal use[J]. Chin Pharm(中国药师), 2017, 20(11):1983-1986.
[15]
MA J B,QU Q,DONG K,et al. Study on in vitro dissolution and drug release for ibuprofen in situ gel [J]. Northwest Pharm J (西北药学杂志),2013,28(5):513-514.
[16]
YIN Y Z,CHEN L,XIE X L, et al. Preparation and in vitro evaluation of mesalazine thermosensitive in situ gel for rectum [J]. Chin J New Drugs(中国新药杂志),2019,28(12):1484-1489.
[17]
FATHALLA Z, VANGALA A, LONGMAN M, et al. Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: design, characterisation, toxicity and transcorneal permeation studies[J]. Eur J Pharm Biopharm, 2017, 114:119-134.
[18]
MURA P, MENNINI N, NATIVI C, et al. In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin[J]. Eur J Pharm Biopharm, 2018, 122:54-61.
[19]
KULKARNI J A, AVACHAT A M. Pharmacodynamic and pharmacokinetic investigation of cyclodextrin-mediated asenapine maleate in situ nasal gel for improved bioavailability [J]. Drug Dev Ind Pharm, 2017, 43(2):234-245.
[20]
SHERJE A P, LONDHE V. Development and evaluation of pH-responsive cyclodextrin-based in situ gel of paliperidone for intranasal delivery[J]. AAPS Pharm Sci Tech, 2018, 19(1):384-394.
[21]
FAN H M,CONG Z X,GU F G. Preparation and in vitro properties of thermosensitive in situ nasal gel of donepezil hydrochloride[J]. Cent South Pharm(中南药学), 2018,16(9):1194-1199.
[22]
YE X C, OU J L, HONG B X, et al. Preparation and characteristics of itraconazole vaginal thermosensitive in situ gels [J]. Cent South Pharm(中南药学),2014,12(6):551-556.
[23]
HU X, HU R F, BAI Z W. Optimization and evaluation of a pH-sensitive in situ gel of nystatin for vaginal delivery system [J]. Chin J New Drugs(中国新药杂志),2013,22(15):1812-1818.
2020, Vol. 55 
